Diala Ezzeddine
President chez Xios Therapeutics, Inc.
Profil
Diala Ezzeddine is a trustee at Buckingham Browne & Nichols School and the president of Xios Therapeutics, Inc. She previously worked as the chief business officer at X-Chem, Inc.
Postes actifs de Diala Ezzeddine
| Sociétés | Poste | Début |
|---|---|---|
Xios Therapeutics, Inc.
 Xios Therapeutics, Inc. BiotechnologyHealth Technology Xios Therapeutics, Inc. is a biotechnology company that develops novel small molecule therapeutics capable of preventing tumors from evading the immune system. It focuses on immuno-oncology pathways and mechanisms that can be best targeted by small molecule therapeutics. The company was founded on October 16, 2015 and is headquartered in Boston, MA. | President | - |
Buckingham Browne & Nichols School
 Buckingham Browne & Nichols School Other Consumer ServicesConsumer Services Buckingham Browne & Nichols School provides education services. The company is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Diala Ezzeddine
| Sociétés | Poste | Fin |
|---|---|---|
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Buckingham Browne & Nichols School
Buckingham Browne & Nichols School Other Consumer ServicesConsumer Services Buckingham Browne & Nichols School provides education services. The company is headquartered in Cambridge, MA. | Consumer Services |
Xios Therapeutics, Inc.
Xios Therapeutics, Inc. BiotechnologyHealth Technology Xios Therapeutics, Inc. is a biotechnology company that develops novel small molecule therapeutics capable of preventing tumors from evading the immune system. It focuses on immuno-oncology pathways and mechanisms that can be best targeted by small molecule therapeutics. The company was founded on October 16, 2015 and is headquartered in Boston, MA. | Health Technology |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |